Brighthouse Financial (BHF)

Nasdaq Financials Life & Health Insurance S&P MidCap 400
$42.60
+1.50 (+3.65%)
Close of Nov 06, 2026 · end-of-day data
Next earnings date
Not scheduled yet
No report date announced in the next three weeks.
Consensus EPS estimate
—
Shown once a date is announced.
Last report (Nov 05)
$9.12 vs $5.03 est.
Surprise +81.3%

Earnings surprise history

reported EPS vs consensus
ReportedQuarterEPS estimateReported EPSSurprise
Nov 05, 2026Sep/2026$5.03$9.12+81.3%

Our record of BHF's reports since we began tracking; it grows each quarter.

Latest results, in brief

All BHF 8-K briefs →
Nov 5, 5:05 PM ET

Brighthouse Financial Q3 adjusted earnings fall to $527 million from $970 million

Negative earnings 2.02

Brighthouse Financial reported third quarter 2026 net income available to shareholders of $302 million, or $5.21 per diluted share, down from $453 million, or $7.89 per share, a year earlier. Adjusted earnings fell to $527 million, or $9.12 per share, from $970 million, or $16.87 per share, though the company said its annual actuarial review added $314 million of net favorable notable items. The company also said regulatory approvals for the pending $70.00 per share Aquarian Capital acquisition are not expected before the December 6, 2026 Outside Date, and the parties are discussing an extension.

  • Net income available to shareholders was $302 million, or $5.21 per diluted share, versus $453 million, or $7.89 per share, in the third quarter of 2025.
  • Adjusted earnings, less notable items, were $213 million, or $3.68 per diluted share, versus $261 million, or $4.54 per share, a year earlier.
  • Annuity sales were $2.4 billion, including $2.1 billion of Shield Level Annuities, with annuity sales down 12% quarter-over-quarter.
  • The merger agreement's Outside Date is December 6, 2026; the company and Aquarian Capital are discussing an extension, with no assurance of agreement.
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.

Quarter endedRevenueYoYEPS (diluted)YoYNet incomeNet margin
Sep 2026$853.00M-53.0% $5.21-34.0% $328.00M38.5%
Jun 2026$1.62B+86.2% $16.53+1520.6% $981.00M60.5%
Mar 2026$1.53B-36.1% $-13.82— -$766.00M-50.2%
Dec 2025$1.69B+40.2% $1.93-81.5% $137.00M8.1%
Sep 2025$1.82B-10.0% $7.89+219.4% $479.00M26.4%
Jun 2025$871.00M-39.0% $1.02+750.0% $85.00M9.8%
Mar 2025$2.39B+3129.7% $-5.04— -$268.00M-11.2%
Dec 2024$1.21B-13.9% $10.46— $671.00M55.7%

From Brighthouse Financial's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.

Annual results

Fiscal yearRevenueGrowthEPS (diluted)GrowthNet margin
FY2025$6.77B+43.2% $5.71+23.1%6.4%
FY2024$4.72B+14.7% $4.64—8.2%
FY2023$4.12B-40.1% $-18.39-135.8%-27.0%
FY2022$6.87B+38.1% $51.30+179.0%56.4%
FY2021$4.98B-41.5% $18.39—33.0%

Frequently asked questions

When is Brighthouse Financial's next earnings date?

Brighthouse Financial has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.

What did Brighthouse Financial earn last quarter?

For the quarter ended Sep 2026, Brighthouse Financial reported diluted EPS of $5.21 (-34.0% year over year) on revenue of $853.00M (-53.0%).

Where do these numbers come from?

Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.

Not investment advice. Figures can be restated by the company in later filings.